Description: Retatrutide is an investigational multi‑agonist peptide that activates GLP‑1, GIP, and glucagon receptors to promote weight loss and improve metabolic and glycaemic parameters. Supplied for pharmacology and metabolic research into appetite regulation, energy balance, and glucose homeostasis.
Intended use: RESEARCH CHEMICAL — for in vitro testing and laboratory or regulated clinical research by qualified professionals only. Not for administration to humans or animals outside approved studies. Not a drug, food, or cosmetic; do not misbrand, misuse, or mislabel.